Evaluation of Persistent Fatigue When Home Sleep Test Is Normal

1. Indication for In‑Laboratory Polysomnography (PSG)

The American Academy of Sleep Medicine (AASM) strongly recommends that any patient with a negative, inconclusive, or low‑AHI home sleep apnea test (HSAT) who still has clinical suspicion for sleep‑disordered breathing should proceed directly to in‑laboratory PSG. 1
Proceeding directly to PSG is advised because a low‑AHI or negative HSAT cannot rule out sleep‑disordered breathing or other sleep disorders that may be causing fatigue. [2][3]1

HSATs lack EEG, EOG, and EMG sensors, so they cannot detect respiratory effort‑related arousals (RERAs) that fragment sleep without producing full apneas or hypopneas. [2][3]
Without EEG‑based sleep staging, HSATs miss hypopneas that terminate only with cortical arousals, leading to false‑negative results especially in mild‑to‑moderate obstructive sleep apnea. 3

PSG quantifies sleep efficiency, sleep‑stage distribution, and the arousal index, allowing detection of sleep fragmentation from non‑apneic causes. 1
PSG can diagnose periodic limb movement disorder, which is completely missed on HSATs. 1
PSG is required to identify central sleep apnea, sleep‑related hypoventilation, and other breathing disorders that need EEG‑based staging for accurate classification. 1
PSG enables detection of paradoxical insomnia (sleep‑state misperception) by comparing objective sleep time with the patient’s subjective report. 1

Evaluate for restless legs syndrome (uncomfortable leg sensations, urge to move, evening worsening) – not captured by any sleep study. 1
Screen for circadian‑rhythm disorders by reviewing sleep‑wake timing, work schedule, and symptom variation on weekends or vacations. 1
Assess for sleep‑related movement disorders beyond HSAT capability, such as bruxism and rhythmic movement disorder. 1
Check for thyroid dysfunction, iron deficiency (ferritin), and vitamin D deficiency, which commonly cause fatigue that mimics or coexists with sleep disorders. 1
Use validated instruments to screen for depression and anxiety, frequent contributors to fatigue and non‑restorative sleep independent of breathing disorders. 1
Review the patient’s medication list for sedating or alertness‑impairing agents (e.g., antihistamines, β‑blockers, benzodiazepines). 1

Do not rely solely on an AHI < 5 as a marker of clinical insignificance; patients with low AHI but elevated RERAs may have clinically important sleep‑disordered breathing.
Normal overnight oximetry does not exclude sleep‑disordered breathing, because RERAs can cause significant sleep fragmentation while preserving oxygen saturation. 4
Avoid repeat HSATs after an initial negative/low‑AHI result; they are likely to reproduce the same findings and delay definitive diagnosis—proceed to PSG instead. 1
Do not dismiss fatigue as merely stress or depression without objective sleep evaluation; untreated sleep disorders worsen quality of life and increase cardiovascular risk. [3][1]

Home sleep apnea tests (HSATs) typically underestimate the severity of obstructive sleep apnea (OSA) by approximately 10-26% compared to in-laboratory polysomnography (PSG), according to the American Academy of Sleep Medicine 5
The American Academy of Sleep Medicine acknowledges that due to technical limitations, HSATs may underestimate the severity of OSA 5
HSATs lack electroencephalography (EEG), electrooculography (EOG), and electromyography (EMG) sensors, which are required to accurately determine sleep versus wake states, as noted by the American Academy of Sleep Medicine 5
Automatic scoring algorithms in HSATs have limited diagnostic accuracy and are not set up to detect other abnormal findings that may indicate underlying pulmonary disease, according to the American Academy of Sleep Medicine 5

In a study by Masa et al., home-based therapeutic decisions were adequate when AHI was high but deficient in patients with mild to moderate AHI, as reported in a study published in Annals of Internal Medicine 6, 7
In a head-to-head study of 100 children, the disparity between PSG and HSAT could have significantly affected clinical management decisions in 23% of patients, according to the American Academy of Sleep Medicine 8

The American Academy of Sleep Medicine recommends that raw HSAT data be reviewed and interpreted by a physician who is either board-certified in sleep medicine or overseen by a board-certified sleep medicine physician 5
HSATs typically do not include CO2 monitoring, which is important for detecting hypoventilation, especially in pediatric populations, as noted by the American Academy of Sleep Medicine 8